SEC EDGAR filings, ownership reports, and insider transactions for ATP Life Science Ventures, L.P..
Recent SEC filings for ATP Life Science Ventures, L.P. including 13F-HR, SC 13G/A, 4 and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 21 Jan 2022 | 31 Dec 2021 | 028-19729 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 21 Jan 2022 | ||
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 20 Oct 2021 | 30 Sep 2021 | 028-19729 | |
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 04 Aug 2021 | 30 Jun 2021 | 028-19729 | |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 30 Jun 2021 | 28 Jun 2021 | 001-38938 |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 30 Jun 2021 | 28 Jun 2021 | 001-38944 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 29 Jun 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 29 Jun 2021 | ||
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 12 May 2021 | 31 Mar 2021 | 028-19729 | |
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 03 Feb 2021 | 31 Dec 2020 | 028-19729 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | FROM SC 13D/A | 27 Nov 2020 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 25 Nov 2020 | 24 Nov 2020 | 001-38938 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SCHEDULE 13G | 16 Nov 2020 | ||
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 06 Nov 2020 | 30 Sep 2020 | 028-19729 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 14 Jul 2020 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 14 Jul 2020 | 10 Jul 2020 | 001-38944 |
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 10 Jul 2020 | 30 Jun 2020 | 028-19729 | |
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 06 May 2020 | 31 Mar 2020 | 028-19729 | |
| 13F-HR | Open 13F-HR document | View SEC filing for 13F-HR | 03 Feb 2020 | 31 Dec 2019 | 028-19729 | |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SC 13D | 01 Jul 2019 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SC 13D | 01 Jul 2019 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 25 Jun 2019 | 24 Jun 2019 | 001-38944 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 | 21 Jun 2019 | 21 Jun 2019 | 001-38938 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 19 Jun 2019 | 19 Jun 2019 | 001-38944 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 | 18 Jun 2019 | 18 Jun 2019 | 001-38938 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D - AMEND. 3 | 28 Jun 2016 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D - AMEND. 2 | 03 Jun 2016 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | DERMIRA, INC. - AMEND. #1 | 12 Feb 2016 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | TITAN PHARMACEUTICALS, INC.-AMEND. #1 | 12 Feb 2016 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | CERECOR INC. | 12 Feb 2016 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 20 Oct 2015 | 20 Oct 2015 | 001-37590 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 14 Oct 2015 | 14 Oct 2015 | 001-37590 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | DERMIRA, INC. | 17 Oct 2014 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2014 | 22 Sep 2014 | 001-36620 |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 04 Dec 2013 | 25 Nov 2013 | 000-27436 |
ATP Life Science Ventures, L.P. files with the SEC under CIK 0001593440. This page aggregates EDGAR filings and related ownership activity.